Abstract
Monitoring gene expression in vitro and in vivo, is crucial when analyzing osteogenesis and developing effective bone gene therapy protocols. Until recently, molecular analytical tools were only able to detect protein expression either in vitro or in vivo. These systems include histology and immunohistochemistry, fluorescent imaging, PET (micro-PET), CT (micro-CT), and bioluminescent imaging. The last is the only system to date that can enable efficient quantitative monitoring of gene expression both in vitro and in vivo. Effective bioluminescent imaging in bone can be achieved by using transgenic mice harboring the luciferase reporter gene, downstream of an osteogenesis specific promoter. The aim of this chapter is to comprehensively describe the various protocols needed for the detection of bioluminescence in bone development and repair.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Bar, I., Zilberman, Y., Zeira, E., et al. (2003) Molecular Imaging of the skeleton: quantitative real time bioluminescence in transgenic mice. J Bone Miner Res 18, 570–578.
2. Wu, J. C., Sundaresan, G., Iyer, M., et al. (2001) Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 4, 297–306.
3. Honigman, A., Zeira, E., Ohana, P., et al. (2001) Imaging transgene expression in live animals. Mol Ther 4, 239–249.
4. Contag, P. R., Olomu, I. N., Stevenson, D. K., et al. (1998) Bioluminescent indicators in living mammals. Nat Med 4, 245–247.
5. Lian, J. B., Stein, G. S., Stein, J. L., et al. (1998) Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth an differentiation. J Cell Biochem 30/31, 62–72.
6. Hauschka, P. V., Lian, J. B., Cole, D. E. C., et al. (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69, 990–1047.
7. Sims, N. A., White, C. P., Sunn, K.L., et al. (1997) Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo. Mol Endocrinol 11, 1695–1708.
8. Thomas, G. P., Bourne, A., Eisman, J. A., et al. (2000) Species-divergent regulation of human and mouse osteocalcin genes by calciotropic hormones. Exp Cell Res 258, 395–402.
9. Zhao, G., Monier-Faugere, M. C., Langub, M. C., et al. (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141, 2674–2682.
10. Clemens, T. L., Tang, H., Maeda, S., et al. (1997) Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J Bone Miner Res 12, 1570–1576.
11. Lavon, I., Goldberg, I., Amit, S., et al. (2000) High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med 6, 573–577.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zilberman, Y., Gafni, Y., Pelled, G., Gazit, Z., Gazit, D. (2008). Bioluminescent Imaging in Bone. In: Westendorf, J.J. (eds) Osteoporosis. Methods In Molecular Biology™, vol 455. Humana Press. https://doi.org/10.1007/978-1-59745-104-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-104-8_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-828-7
Online ISBN: 978-1-59745-104-8
eBook Packages: Springer Protocols